ArticleClinical kidney journal2024

Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic.

Mingyue Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.